Healthcare - Biotechnology - NASDAQ - US
$ 0.7206
-3.66 %
$ 10.4 M
Market Cap
-0.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
1.17%
Net Income
Estimate
35.87%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Imunon, Inc.
IMNN has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart IMNN
EBIT FORECAST
EBIT Forecast Chart IMNN
NET INCOME FORECAST
Net Income Chart IMNN